Optimization of viral antigen purification for the production of immunological agents used for treatment and prevention of young livestock infections

Document Type : Research Paper

Authors

1 Scientific Production Technical Center "Zhalyn", Almaty, Kazakhstan

2 Neurox Technology Ltd., Türkiye

3 Institute of Genetics and Physiology, Almaty, Kazakhstan

10.22124/cjes.2026.10053

Abstract

Gastrointestinal diseases in neonatal calves cause significant economic losses to the agricultural sector worldwide. Commonly identified causative agents include viral pathogens such as bovine viral diarrhea virus (BVDV), bovine rotavirus group A (BRVA), bovine coronavirus (BCoV), bovine alpha-herpesvirus type 1 (BoAHV-1), and bovine parainfluenza virus type 3 (BPI3V). Clinical manifestations of the infections include diarrhea, dehydration, weight loss, reduced milk production, and, in severe cases, fatal outcomes, primarily among calves under one month of life, with mortality rates reaching 50%. The production of effective hyperimmune sera and immunological drugs requires high-quality viral antigens with enhanced immunogenic properties, which determines the need to develop optimized technologies for virus purification and concentration. This study was conducted in 2025 at the “Biogenic Preparations” laboratory of the “Zhalyn” Scientific-Production Technological Center in Almaty, Kazakhstan, to evaluate and optimize various methods for purifying viral antigens used in the production of immunological preparations. Five major viral pathogens of cattle were cultivated in MDBK cell cultures and treated with four different concentration methods: precipitation with polyethylene glycol (PEG) of various molecular weights, ammonium sulfate precipitation, ultrafiltration, and high-speed ultracentrifugation.
The experimental results demonstrated all tested methods increased the concentration of viral particles and enhanced the infectious activity of the suspension, in varying degrees. Precipitation with PEG molecular weight 6,000 at a concentration of 7.5% yielded optimal results, providing a significant increase in infectious activity of 2 log units. Precipitation with ammonium sulfate led to a moderate increase in concentration with an enhancement of viral activity by approximately 1 log unit. Ultrafiltration demonstrated exceptional efficacy, achieving concentration factors ranging from 10 to 50 times with maximum activity values comparable to PEG purification, while providing the advantages of purification through the removal of minor impurities. Ultracentrifugation, while demonstrating a less significant increase in titer (by 0.5–0.7 log units), provided superior purification quality, which is critical for high-quality therapeutic products. Statistical analysis using ANOVA and Tukey’s multiple comparison tests confirmed the significance of the differences observed (p < 0.05). These findings demonstrate that ultrafiltration and PEG precipitation represent the most effective methods for increasing viral titer with minimal loss of biological activity, making them ideal for large-scale production of diagnostic and therapeutic products. Ultracentrifugation, despite lower concentration rates, provides levels of purity essential for research and specialized therapeutic applications. The study demonstrates that an integrated strategy combining multiple concentration methods optimizes both the quality and activity of viral preparations. The study’s findings present opportunities for optimizing biotechnology production and veterinary pharmaceuticals by standardizing protocols for the concentration of viral antigens used to prevent and treat gastrointestinal diseases in cattle.

Keywords


Bachofen, C, Braun, U, Hilbe, M, Ehrensperger, F, Stalder, H & Peterhans, E 2010, Clinical appearance and pathology of cattle persistently infected with bovine viral diarrhoea virus of different genetic subgroups. Veterinary Microbiology, 141(3–4): 258–267. DOI: 10.1016/j.vetmic.2009.09.022.
Brandão, PE, Gregori, F, Sforsin, AJ, Villarreal, LYB & Jerez, JA 2007, Winter dysentery in cows associated with bovine coronavirus (BCoV). Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 59(4): 1074–1076. DOI: 10.1590/S0102-09352007000400038.
Brodersen, BW 2014, Bovine viral diarrhea virus infections. Veterinary Pathology, 51(2): 453–464. DOI: 10.1177/0300985813520250.
Bulatov, Y, Kurmasheva, A, Amanova, Z, Abitaev, R, Sametova, Z, Kyrgyzbayeva, A, Kondybaeva, Z, Turyskeldi, S, Ussembay, A, Toktyrova, D, Mazbayeva, D, Shayakhmetov, Y, Kerimbayev, A, Khussainov, D, Wentao, M, Rsaliyev, A & Abduraimov, Y 2025, The influence of the associated inactivated vaccine against infectious rhinotracheitis and bovine viral diarrhea on the formation and duration of colostral immunity in Kazakh whiteheaded calves. Vaccines, 13(4): 408. DOI: 10.3390/vaccines13040408.
Calderón, M, Fernández, A, Arnal, JL, Baselga, C, Zuñiga, AB, Fernández-Garyzábal, J F, Isabel, A & Cid, D 2023, Cluster analysis of bovine respiratory disease (BRD)-associated pathogens shows the existence of two epidemiological patterns in BRD outbreaks. Veterinary Microbiology, 280: 109701–109701. DOI: 10.1016/j.vetmic.2023.109701.
Chae, J-B, Kim, WG, Song, S & Chae, J-S 2025, Molecular characterization of ten viral pathogens causing calf diarrhea in Hanwoo (Bos taurus coreanae) by next generation sequencing. BMC Veterinary Research, 21(1). DOI: 10.1186/s12917-025-04926-2.
Chauhan, N, Tiwari, S, Iype, T & Jain, U 2017, An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators. Expert Review of Vaccines, 16(5): 491–502. DOI: 10.1080/14760584.2017 .1306440.
Díaz Alarcón, RG, Liotta, DJ & Miño, S 2022, Zoonotic RVA: State of the art and distribution in the animal world. Viruses, 14(11): 2554. DOI: 10.3390/v14112554.
Fray, M 2000, Bovine viral diarrhoea virus: Its effects on ovarian function in the cow. Veterinary Microbiology, 77(1–2): 185–194. DOI: 10.1016/S0378-1135(00)00275-3.
Furlan, CRC, Agnol, AMD, Frucchi, APS, Vogel, CIG, Ollhoff, RD, Alfieri, AA & Sotomaior, CS 2025a, Molecular detection of bovine coronavirus in the environment of a naturally infected dairy cattle herd. Tropical Animal Health and Production, 57(7). DOI: 10.1007/s11250-025-04585-3.
Furlan, CRC, Agnol, AMD, Frucchi, APS, Vogel, CIG, Ollhoff, RD, Alfieri, AA & Sotomaior, CS 2025b, Molecular detection of bovine coronavirus in the environment of a naturally infected dairy cattle herd. Tropical Animal Health and Production, 57(7). DOI: 10.1007/s11250-025-04585-3.
Huang, Y, Li, Z, Fu, Y, Wang, SQ, Kang, M & Meng, R 2025, Diagnosis of bovine rotavirus: An overview of currently available methods. Frontiers in Microbiology, 16. DOI: 10.3389/fmicb.2025.1550601.
Karimi, O, Bitaraf Sani, M, Bakhshesh, M, Zareh Harofteh, J & Poormirzayee-Tafti, H 2022, Prevalence of bovine herpesvirus 1 antibodies and risk factors in dairy cattle of Iran’s central desert. Tropical Animal Health and Production, 55(1). DOI: 10.1007/s11250-022-03426-x.
Khussainov, D, Mukhatayeva, K, Ashirova, Z, Zura, Y, Mutushev, A, Idayat, N, Davletova, A & Karbozova, A 2024, Epizootic measures against infectious and viral animal diseases in Kazakhstan. Caspian Journal of Environmental Sciences, 22(5): 1243–1253. DOI: 10.22124/cjes.2024.8340.
Khusainov, D, Thiessen, I, Berdikulov, M, Sansyzbay, A, Shynybaev, K, Bakieva, F & Lesova, Zh 2026, Use of a biogenic drug for polyetiological diarrhea in calves. Animal Health and Biosafety, 82(3): 377–389. DOI: 10.52578/3134-8114-2026-3-377-389.
Kincade, JN, Engle, TE, Henao-Tamayo, M, Eder, JM, McDonald, EM, Deines, DM, Wright, BM, Murtazina, D, Bishop, JV, Hansen, TR & Van Campen, H 2025, Postnatal epigenetic differences in calves following transient fetal infection with bovine viral diarrhea virus. BMC Genomics, 26(1). DOI: 10.1186/s12864-025-11562-5.
Kostanić, V, Kunić, V, Šimac, MP, Lolić, M, Sukalić, T & Brnić, D 2024, Comparative insights into acute gastroenteritis in cattle caused by bovine rotavirus A and bovine coronavirus. Veterinary Sciences, 11(12): 671–671. DOI: 10.3390/vetsci11120671.
La Polla, R, Testard, M-C, Goumaidi, A, Chapot, E, Legras-Lachuer, C & de Saint-Vis, B 2022, Identification of differentially expressed gene pathways between cytopathogenic and non-cytopathogenic BVDV-1 strains by analysis of the transcriptome of infected primary bovine cells. Virology, 567: 34–46. DOI: 10.1016/j. virol.2021.12.005.
Levitz, SM & Golenbock, DT 2012, Beyond empiricism: Informing vaccine development through innate immunity research. Cell, 148(6): 1284–1292. DOI: 10.1016/j.cell.2012.02.012.
Liu, C, Lin, J, Yang, H, Li, N, Tang, L, Neumann, D, Ding, X & Zhu, L 2023, NFAT5 restricts bovine herpesvirus 1 productive infection in MDBK cell cultures. Microbiology Spectrum, 11(4). DOI: 10.1128/spectrum.00117-23.
Liu, W, Zhang, K, Cheng, J, Yu, S, Cheng, C, Jiang, B, Zhou, L & Li, Y 2024, Development and evaluation of a time-resolved fluorescence labelled immunochromatographic strip assay for rapid and quantitative detection of bovine herpesvirus 1. Frontiers in Microbiology, 15. DOI: 10.3389/fmicb.2024.1371849.
Mutushev, AZh 2025, Hyperimmune sera in the treatment and prevention of diarrhea in neonatal calves. Journal of Information Systems Engineering and Management, 10(44s): 649–654. DOI: 10.52783/jisem.v10i44s.8646.
Olsen, JE, Svensmark, B, Agerskov, L, Albrechtsen, M & Olsen, RH 2025, Prevalence and infection characteristics of common pathogens associated with calf diarrhoea in Danish dairy calves. Veterinary Microbiology, 307: 110575. DOI: 10.1016/j.vetmic.2025.110575.
Ostler, JB & Jones, C 2023, The bovine herpesvirus 1 latency-reactivation cycle, a chronic problem in the cattle industry. Viruses, 15(2): 552. DOI: 10.3390/v15020552.
Sedky, D, Ghazy, AA & Abou-Zeina, HAA 2025, Advances in diagnosis of diseases causing diarrhea in newborn calves. Veterinary Research Communications, 49(5). DOI: 10.1007/s11259-025-10855-0.
Stipp, DT, Barry, AF, Alfieri, AF, Takiuchi, E, Amude, AM & Alfieri, AA 2009, Frequency of BCoV detection by a semi-nested PCR assay in faeces of calves from Brazilian cattle herds. Tropical Animal Health and Production, 41(7): 1563–1567. DOI: 10.1007/s11250-009-9347-2.